Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy.

Abstract

No abstract available.

Authors
  • Askin F
  • Gabrielson E
  • Li QK
  • Osmani L
PubMed ID
Appears In